COVID-19

Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) JPEO-CBRND, on behalf of the Defense Health Agency, for two nationwide clinical trials.

The Johns Hopkins Bloomberg School of Public Health, with Bloomberg Philanthropies, today announced a free new online course to help public health officials implement strong contact tracing programs to break the chain of novel coronavirus transmission.

As mounting evidence suggests that SARS-CoV-2 is airborne, we look back at the first controlled experiment that proved the airborne spread of respiratory disease—and at how those findings inform today’s COVID-19 response.

There are significant considerations to be made in terms of how to vaccinate a global population. Chief among them will be addressing concerns about the vaccine itself—especially one produced on an accelerated timeline.

A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population.